Results 211 to 220 of about 57,705 (278)

Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report. [PDF]

Cureus
Gayford K, O'Neill N, Hadeya A, Ottaviani D.   +3 more
europepmc   +1 more source

Patterns of bone density evaluation in a community population treated with aromatase inhibitors

, 2012
Jennifer A. Ligibel, A. James O’Malley, Maxine D. Fisher, Gregory W. Daniel, Eric P. Winer, Nancy L. Keating   +5 more
openalex   +2 more sources

The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents. [PDF]

J Clin Endocrinol Metab
Cui Y, Zhang Q, Hou L, Luo X.
europepmc   +1 more source

Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling. [PDF]

BMC Cancer
Ojedele OA, Hamdi N, Mughram MHA, Alyami EM, Dauelbait M, Almohammed OA.   +5 more
europepmc   +1 more source

Comparative effectiveness of bone-protective interventions for aromatase inhibitors-induced bone loss in postmenopausal women with early breast cancer: a network meta-analysis. [PDF]

Front Oncol
Xu Y, Lai J, Mai M, Tang Y, Wu Z.
europepmc   +1 more source

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors. [PDF]

Breast Cancer Res Treat
Brown NL, Howell SJ, Papantoniou D, Eriksson O, Bergqvist M, Williams A, Kavanagh A, Backlund A, Albu-Kareem A, Elinder E, Larsson K, Uminska M, Ekholm M.   +12 more
europepmc   +1 more source

Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors? [PDF]

Cardiooncology
Kwaah PA, Mensah SA, Agyemang EA, Kekrebesi JS, Katkov D, Carboo A, Appah G, Rashid HA, Kwan JM.   +8 more
europepmc   +1 more source

Evaluation of the biochemical activity of new modified steroids as aromatase inhibitors

, 2004
Margarida Cepa, Georgina Correia‐da‐Silva, E. Tavares da Silva, Fernanda M.F. Roleira, Naa Teixeira   +4 more
openalex   +1 more source

Real-World Effectiveness and Safety of Ribociclib Plus Aromatase Inhibitors in Patients with HR+/HER2- Metastatic Breast Cancer: A Multicenter Experience from Vietnam. [PDF]

Asian Pac J Cancer Prev
Nguyen HT, Le QV, Phung HT, Nguyen QH, Vu HTM, Truong MC.   +5 more
europepmc   +1 more source

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York Cancer Consortium trial [PDF]

, 2016
et al,, Ma, Cynthia X, Naughton, Michael
core   +2 more sources